paper-with-me

홈 › Papers

The interactions of SARS-CoV-2 with co-circulating pathogens: Epidemiological implications and current knowledge gaps

2022-05-16 · Anabelle Wong, Laura Barrero, Elizabeth Goult, Michael Briga, Sarah C. Kramer, Aleksandra Kovacevic, Lulla Opatowski, Matthieu Domenech de Cellès

Despite the availability of effective vaccines, the persistence of SARS-CoV-2 suggests that co-circulation with other pathogens and resulting multi-epidemics may become increasingly frequent. To better forecast and control the risk of such multi-epidemics, it is essential to elucidate the potential interactions of SARS-CoV-2 with other pathogens; these interactions, however, remain poorly defined. Here, we aimed to review the current body of evidence about SARS-CoV-2 interactions. To study pathogen interactions in a systematic way, we first developed a general framework to capture their major components: sign, strength, symmetry, duration, and mechanism. We then reviewed the experimental evidence from animal models about SARS-CoV-2 interactions. Of the 14 studies identified, 11 focused on the outcomes of co-infection with non-attenuated influenza A viruses and generally demonstrated that co-infection increased disease severity compared with either mono-infection. By contrast, the effect of co-infection on the viral load of either virus was variable and inconsistent across studies. Next, we reviewed the epidemiological evidence about SARS-CoV-2 interactions in human populations. Although numerous studies were identified, only few were specifically designed to infer interaction and many were prone to multiple biases, including confounding. Nevertheless, their results suggested that influenza and pneumococcal conjugate vaccinations were associated with reduced riskof SARS-CoV-2 infection. Finally, we formulated simple transmission models of SARS-CoV-2 co-circulation with a viral or a bacterial pathogen, showing how they can naturally incorporate the proposed framework. More generally, we argue that such models, when designed with an integrative and multidisciplinary perspective, will be invaluable tools to resolve the substantial uncertainties that remain about SARS-CoV-2 interactions.

📄 PDF Abstract BibTeX arXiv:2205.07553

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Concepts and methods for predicting viral evolution

2024-03-19 · Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, Malancha Karmakar 외

The seasonal human influenza virus undergoes rapid evolution, leading to significant changes in circulating viral strains from year to year. These changes are typically driven by adaptive mutations, particularly in the a…

Persistence of the Omicron variant of SARS-CoV-2 in Australia: The impact of fluctuating social distancing

2022-11-20 · Sheryl L. Chang, Quang Dang Nguyen, Alexandra Martiniuk, Vitali Sintchenko 외

We modelled emergence and spread of the Omicron variant of SARS-CoV-2 in Australia between December 2021 and June 2022. This pandemic stage exhibited a diverse epidemiological profile with emergence of co-circulating sub…

Modelling the effect of within-host dynamics on the diversity of a multi-strain pathogen

2021-11-15 · Nefel Tellioglu, Nicholas Geard, Rebecca H. Chisholm

Multi-strain pathogens such as Group A Streptococcus, Streptococcus pneumoniae, and Staphylococcus aureus cause millions of infections each year with a substantial health burden. Control of multi-strain pathogens can be …

Diversity

Antigenic waves of virus-immune co-evolution

2021-02-20 · Jacopo Marchi, Michael Lässig, Aleksandra M. Walczak, Thierry Mora

The evolution of many microbes and pathogens, including circulating viruses such as seasonal influenza, is driven by immune pressure from the host population. In turn, the immune systems of infected populations get updat…

Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

2021-02-01 · Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng 외

The deadly coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has gone out of control globally. Despite much effort by scientists, medical experts, and soc…

Drug Discovery